NASDAQ · Biotechnology

Gossamer Bio, Inc. (GOSS) Stock

$9.31 -5.77% NASDAQ: GOSS Healthcare

Valuation

MetricValue
Price$9.31
Market Cap$56.89M
P/E Ratio-0.22
P/B Ratio-0.30
P/S Ratio1.17
EPS (TTM)$-0.75
52-Week High$309.60
52-Week Low$9.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE108.75%
ROA-162.91%
ROCE272.66%
Gross Margin-341.67%
Operating Margin-339.58%
Net Margin-235.00%
Debt/Equity-0.42
Current Ratio2.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$115.0M$48.0M
Operating Profit$-216.0M$-219.0M$-184.0M$-60.0M$-163.0M
Net Profit$-234.0M$-229.0M$-180.0M$-57.0M$-170.0M
EPS$-250.13$-216.97$-94.26$-19.99$-59.64
Op Margin———-52.2%-336.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$344.0M$272.0M$312.0M$315.0M$172.0M
Total Liabilities$222.0M$260.0M$249.0M$286.0M$295.0M
Cash$183.0M$112.0M$32.0M$46.0M$38.0M
Borrowings$185.0M$226.0M$212.0M$203.0M$203.0M

Latest News

Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes Simply Wall St. · Jul 2, 2026 Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants Business Wire · Jul 1, 2026 Gossamer Bio (GOSS) Stock Faces Mixed Analyst Target Changes On Funding Risk Simply Wall St. · Jun 18, 2026 Gossamer Bio Inc (GOSS) Q1 2026 Earnings Call Highlights: Strategic Debt Reduction and ... GuruFocus.com · Jun 17, 2026 Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes Business Wire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-189.0M$-187.0M$-159.0M$-3.0M$-171.0M
Investing Cash Flow$-119.0M$-2.0M$-111.0M$29.0M$156.0M
Financing Cash Flow$3.0M$3.0M$0$1.0M$0
Net Cash Flow$-303.0M$-71.0M$-80.0M$14.0M$-8.0M
Free Cash Flow$-191.0M$-188.0M$-159.0M$-3.0M$-171.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-0.29
FCF Yield-261.43%
Quick Ratio0.53
Interest Coverage-15.16
Return 1Y-89.31%
Return 3Y-89.60%
Return 5Y-97.88%

Ownership

Insiders Held1.52%
Institutions Held73.64%
Institutions Float Held74.78%
Institutional HolderSharesReport Date
Blackrock Inc.16,826,6952026-03-31
Kalehua Capital Management LLC10,236,2932026-03-31
AQR Capital Management, LLC10,126,8972026-03-31
Vanguard Capital Management LLC9,394,5932026-03-31
Arch Venture Management, Llc8,055,9162026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRVSCorvus Pharmaceuticals, Inc. $10.52 +3.04% -17.03 $884.63M 0.00%
FDMT4D Molecular Therapeutics, Inc. $13.33 +4.96% -5.03 $696.84M 0.00%
KALV $27.00 +0.00% -8.28 $1.44B 0.00%
LXRXLexicon Pharmaceuticals, Inc. $1.68 -4.55% -12.10 $746.25M 0.00%
OLMAOlema Pharmaceuticals, Inc. $7.82 +0.00% -3.81 $683.06M 0.00%

About Gossamer Bio, Inc.

Gossamer Bio, Inc. is led by CEO Faheem Hasnain, employs 144 people, headquartered in US, publicly traded since 2019.

Gossamer Bio, Inc. (GOSS) stock trades at $9.31 with a market capitalization of $56.89M. The stock is valued at a price-to-earnings (P/E) ratio of -0.22, price-to-book of -0.30, price-to-sales of 1.17. Over the past 52 weeks the stock has ranged between $9.10 and $309.60, and currently trades 97.0% below its 52-week high.

On profitability, Gossamer Bio, Inc. generates a return on equity (ROE) of 108.75% — well above the market average, a sign of a high-quality business, return on capital employed of 272.66%, an operating margin of -339.58%, a net profit margin of -235.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides